Ligand

Ligand Appoints Martine Zimmermann to its Board of Directors

September 26, 2023 05:05 PM Eastern Daylight Time SAN DIEGO – Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced the appointment of Martine Zimmermann, PharmD, to its Board of Directors as an independent director. Dr. Zimmermann brings 25 years of global experience in the pharmaceutical industry to Ligand’s board. “We are very pleased to welcome Martine to our board of directors. She brings considerable expertise in development and … Continue reading Ligand Appoints Martine Zimmermann to its Board of Directors

National Disease Research Interchange

NDRI Welcomes Tom Malecki as New Chief Financial Officer and Vice President of Administration

September 26, 2023 11:15 AM Eastern Daylight Time PHILADELPHIA–(BUSINESS WIRE)–The National Disease Research Interchange (NDRI) is pleased to welcome Tom Malecki as its new Chief Financial Officer and Vice President of Administration. Malecki brings a wealth of experience and has a proven track record in financial leadership across several industries. He will be responsible for overseeing the organization’s financial operations and playing a crucial role … Continue reading NDRI Welcomes Tom Malecki as New Chief Financial Officer and Vice President of Administration

Matica Biotechnology, Inc.

Matica Bio Appoints Life Sciences Veterans Laura Parks, Heather N. Sugrue to Top Leadership Positions

September 14, 2023 09:00 AM Eastern Daylight Time COLLEGE STATION, Texas–(BUSINESS WIRE)–Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the GMP production of cell and gene therapies (CGT), today announced the appointment of Laura Parks as executive vice president of Commercial Operations and Heather N. Sugrue as vice president of Alliance Management. “I’m excited to join Matica Bio’s team of … Continue reading Matica Bio Appoints Life Sciences Veterans Laura Parks, Heather N. Sugrue to Top Leadership Positions

DNANEXUS

DNAnexus Announces Appointment of Thomas Laur as CEO

Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors September 12, 2023 09:02 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and … Continue reading DNAnexus Announces Appointment of Thomas Laur as CEO

Fractyl Health

Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer

Seasoned Expert Joins to Drive Fractyl’s Pioneering Mission Forward with its Revita® and Rejuva® Programs for Type 2 Diabetes and Obesity Dr. Kieffer’s Stellar Track Record Spans Pioneering Academic Research in Diabetes Mechanisms and Industry Experience with Company Formation and Leadership September 14, 2023 10:08 AM Eastern Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–Fractyl Health, a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic … Continue reading Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer